focus -WSS

focus

author：entertainment 2025-10-01 02:42:37 - browse：352

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Latigo launches with $135 million for Vertex

WSS

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

FogPharma raises $145 million in rare Series E round

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Readout Newsletter: Amylyx, Aurinia, and IQVIA

explore

focus

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ALS groups 'won't be played again' by the FDA, drug sponsors

Drug repurposing or repositioning? The language matters

https://cbu01.alicdn.com/img/ibank/2017/320/543/4482345023_1425734339.220x220xz.jpg

Cancer drug shortages should be causing more outrage

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Malaria cases in Florida and Texas: Here’s what you need to know

RSV vaccines may be linked to small increased risk of developing GBS

After affirmative action ruling, medical educators look to 'holistic review'

Long Covid research funding gets a major boost from NIH

hotspot

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Long Covid research funding gets a major boost from NIH

AMAs digital advisors table RPM coding reform proposal, again

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Long Covid research funding gets a major boost from NIH

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

entertainment

hotspot

knowledge

leisure time